Adherence To Diabetes Care Management and Quality of Life Among Diabetic Persons in Ibadan, Oyo State, Nigeria
Keywords:
Diabetes, quality of life, treatment adherence, predictors of quality of life, glycemic controlAbstract
Diabetes is a challenging health problem that threatens the quality of life of an affected person. It is a progressively increasing metabolic disorder that demands global attention due to its interference with quality of life (QOL). While existing knowledge has established that, diabetes impairs an individual’s well-being and overall QOL; not many studies have focused on the impact of treatment adherence to diabetes management on QOL. Information about QOL and treatment adherence is useful in implementing and evaluating interventions in the management of diabetes.
A descriptive cross-sectional study, with approval obtained from the ethical review committee of the Oyo State Ministry of Health, Nigeria. Purposive sampling was used to select 300 respondents. The interviewer-administered questionnaire contains information on socio-demographics, clinical determinants, adherence to treatment, and QOL. The QOL instrument was adapted from the WHO–QOL bref questionnaire, adherence to treatment from the Morisky treatment adherence tool, and reviewed literature. The data was analyzed using SPSS, with p-value <0.05. Descriptive statistics such as frequencies and percentages explained socio-demographic variables. Associations between selected variables and QOL were explained with inferential statistics. The mean QOL scores were calculated in domains according to the WHOQOL scale. Respondents consisted of 15 type I diabetic patients and 285 type II diabetic patients. Respondent's mean age was 58.77 + 8.51 predominantly females (79.7%) and 58% were Christians. Majority of the respondents were employed (59%) and earned more than 20,000 naira (17.6%). Most of the respondents had uncontrolled blood sugar (58%). The respondents' mean age at onset of diabetes is between age 30 and 60 years (53.28+9.55) with more cases of type II diabetes. Domain-specific quality of life scores is higher in the environmental domain (58.04+ 11.01) as compared to other QOL domains. Also, the study identified forgetfulness as the main reason for non-compliance to drug prescriptions among the respondents.
About 20% skipped their appointment with the physician, while 86.7% followed a diabetic routine diet, and 28.6% engaged in mild to moderate exercise. Generally, patients who adhered to their treatment had controlled blood glucose with higher mean QOL scores in all the domains. The predictors of the QOL domains were identified as: medication adherence and psychological domain (p-value-0.018), age of the respondents and social domain (p-value-0.004), environmental domain and age at onset of diabetes (p-value-0.032); and monthly income is a significant predictor of all the domains of QOL. Conclusively, the mean quality of life domain scores informed average scores relating to patients' adherence to treatment. As such, treatment adherence predicts a good perception of QOL. Also, glycemic control amongst other clinical determinants is capable of influencing a good perception of QOL.
References
Abdul Majeed., Habib Ur Rahman Habib., Iltaf Hussain., Muhammad Fawad Rasool. The Impact of Treatment Adherence on Quality of Life Among Type 2 Diabetes Mellitus Patients-Findings from a Cross-Sectional Study (2021). Patient Preference and Adherence Volume 15:475-481. DOI: 10.2147/PPA.S295012 CC BY-NC 3.0
Acharya LD., Kareem S., Ashan FK., Mallayasamy S. Development and validation of quality-of-life assessment instruments for diabetic patients. Asian J Pharm Health Sci 2014:4(4):1114-1120.
Adil Supiyev. Diabetes Prevalence, Awareness, Treatment and Their Correlates in Older Persons in Urban and Rural Population in the Astana Region, Kazakhstan. Diabetes Res Clin Pract. 2016.№ 4. Р. 45-53
Ali G., Mohammad A., Abasalt B., Faramarz S., Zahra S., Esmail Z., Quality of life in patients with type 2 diabetes. Application of WHOQOL-BREF scale. Shiraz e-Med J. 2013;14(3):162-171.
American Diabetes Association2. Classification and diagnosis of diabetes: standards of medical care in diabetes 2021. Diabetes Care.2021;44 (suppl 1): S15-S33.doi.10.2337/dc21-S002.
Ashraf Eljedi., Rafael T Mikolajczyk., Alexander Kraemer., Ulrich Laaser. Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in the Gaza strip: a cross-sectional study (2015) volume 6, Article number: 268.
Aynalem SB., Zeleke AJ. Prevalence of diabetes mellitus and its risk factors among individuals aged 15 years and above in Mizan-Aman Town, southwest Ethiopia,2016: a cross sectional . Int J Endocrinol. (2018):9317987.doi:1155.
Cho NH., Shaw JE., Karuranga S. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research Clinical Practice. 138:271-281. Doi:10.10166/j.diabetes2018.02.023.
Cicmil A., Govedarica O., Lecic J., Mlais S., Cicmil S., Cakic S. Oral Symptoms and mucosa lesions in patients with diabetes mellitus type 2. Blk J Dent Med. 2017;21(1): 50-54. Doi10.1515
Dahiru T., Jibo A., Hassan AA., Mande AT. Prevalence of diabetes in a semi-urban community in Northern Nigeria. Niger J Med. 2008 Oct-Dec;17(4):414–416.
Farimah Fayyaz., Parham Mardi., Sahar Sobhani., Mostafa Qorbani: Association of quality of life with medication adherence and glycemic control in patients with type 1 diabetes November 2023 Journal of Diabetes & Metabolic Disorders DOI: 10.1007/s40200-023-01351-w
Gerstein HC., Miller ME., Genuth S., Ismail-Beigi F., Buse JB., Goff DC Jr. ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818-28.).
International Diabetes Federation. Diabetes Atlas. 7th ed. Brussels: IDF; 2015. 90-93.
Ivek Bhanubhai Prajapati., Raushan Blake., Leelavathi Dinesh Acharya., Shubha Seshadri. Assessment of quality of life in type II diabetic patients using the modified diabetes quality of life (MDQoL)-17 questionnaire (2017). Braz. J. Pharm. Sci. 53 (4) • https://doi.org/10.1590/s2175-97902017000417144
Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet. 2010 Jun 26;375(9733):2254–2266.
Melissa conrad and stoppler MD(2014): Diabetes newsletter.
Nataliia Yu. Kondratiuk., Rymma P. Tkachenko. Principles and methods of research on the quality of life in patients with diabetes. (2023) DOI:10.31612/2616-4868.4(26).2023.12
Ogurtsova K . IDF Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017.No 5. Р. 108-116.2.
Owoaje EE., Rotimi CN., Kaufman JS., Tracy J., Cooper RS. Prevalence of adult diabetes in Ibadan, Nigeria. East 1997 Africa Med Journal. ;74(5):299–302.
Pouya Saeedi et al. Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019. № 8. Р. 221-229.3.
Rahnuma A., Mainul H. Review article Oral Health Messiers: Diabetes Mellitus Relevance-Diabetes, Metabolic Syndrome and Obesity July 2021: 14:3001-3015. Doi:10.2147/DMSO.S318972.
Ramachandran A., Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009 Mar;1(1):18–28.
WHO Fact sheets /detail/diabetes 5 April 2023., who-global-diabetes-compact. World Health Assembly 2021.
World Health Assembly WHA seventy-fourth (74).4. Agenda item 13.2 31 May 2021
World Health Organization. Health topics /diabetes. 20 Avenue Appia, 1211 Geneva 27, Switzerland. 2021: https://www.who.int/health-topics/diabetes.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Olubunmi O. Esuola

This work is licensed under a Creative Commons Attribution 4.0 International License.